Mostrando 4 resultados de: 4
Antiphospholipid syndrome in Latin American patients: Clinical and immunologic characteristics and comparison with European patients
ArticleAbstract: The objective of this study was to analyse the prevalence and characteristics of the main clinical aPalabras claves:Anticardiolipin antibodies, antiphospholipid antibodies, Antiphospholipid syndrome, ethnicity, Lupus anticoagulantAutores:Bové A., Bucciarelli S., Cervera R., Claudio Galarza, Escárcega R.O., Espinosa G., Font J., García-Carrasco M., Gómez-Ponce M., Gómez-Puerta J.A., Rojas-Rodríguez J.Fuentes:scopusA longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group
ArticleAbstract: Introduction: After more than 20 years of sustained work, the Latin American Group for the Study ofPalabras claves:Biomarkers, Latin American, LUPUS, lupus nephritis, multiethnicAutores:Abud-Mendoza C., Acosta Colman I., Alarcón G.S., Alba Moreyra P.B., Aline Gasparin A., Amezcua-Guerra L.M., Andrés Zúñiga-Vera, Appenzeller S., Arizpe F., Arturi V., Ataide Mariz H., Babini A.M., Berbotto G.A., Bonfá E.S.D.D.O., Borba E.F., Burgos P.I., Cairoli E., Calvo Quiroz A.A., Cardiel M.H., Carolina Londe A., Catoggio L.J., Cavalcanti F.S., Chahuán J.M., Constanza Bertolaccini M., Cosatti M.A., Cristobal M.P., Cunha Andrade C.A.A., Da Silva N.A., Daniele J.A., de los Ángeles Gargiulo M., de Oliveira e Silva Montadon A.C., de Oliveira Martins L.V., de Souza Barbosa V., Duarte Â.L.P., Duarte M., Esquivel-Valerio J.A., Fernández-Ávila D.C., Fragoso-Loyo H.E., Funes Soaje C., García de la Torre I., García M.A., Gobbi C.A., Gomez G.N., Gómez-Puerta J.A., González Lucero L., González-Bello Y.C., Guerra I., Harvey G.B., Haye Salinas M.J., Inés Bellomio V., Kerzberg E., Llanos C., Machado Ribeiro F., Machado Xavier R., Martinez G.A., Matellán C., Maurelli L., Mendes Klumb E., Meras N., Micelli M., Mimica M., Monticielo O.A., Mora-Trujillo C.S., Moreno-Alvarez M.J., Muñoz-Louis R., Neira O., Neves Yuki E.F., Nieto R., Novatti E., Otaduy C.M., Peralta A., Pérez N., Pisoni C.N., Pons-Estel B.A., Pons-Estel G.J., Porta S., Quintana R.M., Quintana-Lopez G., Reátegui-Sokolova C., Rebella M., Rodriguez A.M., Rosas I., Saavedra M.Á., Sato E.I., Sattler M.E., Saurit V., Schmidt Fernandes F., Scolnik M., Seguro L.P.C., Serrano Morales R.M., Soriano E.R., Subilis G., Tavares Brenol J.C., Tereza Lavras Costallat L., Tobón G.J., Torres dos Reis-Neto E., Vásquez G., Wojdyla D.Fuentes:googlescopusFirst Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
ArticleAbstract: Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a sigPalabras claves:lupus nephritis, systemic lupus erythematosus, TreatmentAutores:Acevedo-Vásquez E.M., Acosta Colman M.I., Alarcón G.S., Alba Moreyra P.B., Alvarellos A.J., Amezcua-Guerra L.M., Amigo M.C., Appenzeller S., Aquino A.M., Arturi V., Babini A.M., Barile-Fabris L.A., Berbotto G.A., Betancur G.V., Bonfá E.S.D.D.O., Borba E.F., Brenol J.C.T., Burgos P.I., Cairoli E., Cardiel M.H., Cardoso Linhares F.A., Catoggio L.J., Cavalcanti A., Cavalcanti F.S., Chacón-DÍaz R., Cieza J., Claudio M. Galarza-Maldonado, Collado M.V., Conti S.M., Costallat L.T.L., Criniti J.M., Da Silva N.A., Danza A., Dos Reis Neto E.T., Drenkard C., Duarte M., Eraso Garnica R.M., Espada G., Fragoso-Loyo H.E., Fuentes-Silva Y.J., Gamboa-Cárdenas R.V., García de la Torre I., García M.A., García Valladares I., Gerling C., Gervasoni V.L., Gobbi C.A., Gómez-Martín D., Gómez-Puerta J.A., González Naranjo L.A., González-Bello Y.C., Gordon S., Guibert-Toledano M., Haye Salinas M.J., Herrera Uribe S., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Llanos C., Massardo L., Molina J.F., Montandon De Oliveira E Silva A.C., Monticielo O.A., Montúfar Guardado R.A., Mora-Trujillo C.S., Muñoz-Louis R., Neira O., Orozco M.C., Pera M.A., Pineda-Villaseñor C., Pons-Estel B.A., Pons-Estel G.J., Popoff F., Portela Hernández M., Quintana R.M., Retamozo S., Reyes G.L., Robaina Sevrini R., Rosario V., Sarano J., Sato E.I., Sattler M.E., Saurit V., Savio V., Scherbarth H.R., Scolnik M., Seguro L.P.C., Silva C.A., Silveira L.H., Soriano E.R., Ugarte-Gil M.F., Ugolini-Lopes M.R., Vargas Peña A., Vásquez G., Xavier R.M.Fuentes:scopusPregnancy and catastrophic antiphospholipid syndrome
ReviewAbstract: Antiphospholipid syndrome (APS) is clearly related to maternal morbidity. The most characteristic fePalabras claves:Antiphospholipid syndrome, Catastrophic antiphospholipid syndrome, HELLP syndrome, Pre-eclampsiaAutores:Claudio M. Galarza-Maldonado, Gómez-Puerta J.A., Sanin-Blair J.Fuentes:scopus